Terms: = Skin cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
17 results:
1. nono::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series.
See SHC; Olivares S; Kulkarni M; Dhillon SK; Fumero-Velazquez MS; Hagstrom MNE; Gerami P
J Cutan Pathol; 2023 Nov; 50(11):956-962. PubMed ID: 37606377
[TBL] [Abstract] [Full Text] [Related]
2. Novel nono::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma.
Fritchie KJ; Dermawan JK; Astbury C; Sharma A; Bakhshwin A; Fuller L; Agrawal S; Wieland CN; Greipp PT; Azzato EM; Folpe AL; Billings SD
Virchows Arch; 2023 Aug; 483(2):237-243. PubMed ID: 37468653
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.
Cui H; Qu Y; Zhang L; Zhang W; Yan P; Yang C; Zhang M; Bai Y; Tang M; Wang Y; Chen L; Xiao C; Zou Y; Liu Y; Zhang L; Yang Y; Yao Y; Li J; Liu Z; Yang C; Jiang X; Zhang B
Int J Cancer; 2023 Jul; 153(2):320-330. PubMed ID: 37074298
[TBL] [Abstract] [Full Text] [Related]
4. The caspase-2 substrate p54nrb exhibits a multifaceted role in tumor cell death susceptibility via gene regulatory functions.
Eichler M; Distler U; Nasrullah U; Krishnan A; Kaulich M; Husnjak K; Eberhardt W; Rajalingam K; Tenzer S; Pfeilschifter J; Imre G
Cell Death Dis; 2022 Apr; 13(4):386. PubMed ID: 35444189
[TBL] [Abstract] [Full Text] [Related]
5. Targeting the p300/nono axis sensitizes melanoma cells to BRAF inhibitors.
Zhang F; Tang X; Fan S; Liu X; Sun J; Ju C; Liang Y; Liu R; Zhou R; Yu B; Zhang C; Zhang Z; Kang T; Huang G; Lv XB
Oncogene; 2021 Jun; 40(24):4137-4150. PubMed ID: 34017080
[TBL] [Abstract] [Full Text] [Related]
6. The regulation of nono by USP11 via deubiquitination is linked to the proliferation of melanoma cells.
Feng P; Li L; Dai J; Zhou L; Liu J; Zhao J; Li X; Ling N; Qiu S; Zhang L; Xie T; Chen Y; Donovan MJ; Peng T; Song J; Ye M
J Cell Mol Med; 2021 Feb; 25(3):1507-1517. PubMed ID: 33369124
[TBL] [Abstract] [Full Text] [Related]
7. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
[TBL] [Abstract] [Full Text] [Related]
8. Melanotic PEComa of the Sinonasal Mucosa With nono-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.
McGregor SM; Alikhan MB; John RA; Kotler H; Bridge JA; Mujacic I; Kadri S; Segal J; Krausz T
Am J Surg Pathol; 2017 May; 41(5):717-722. PubMed ID: 28009605
[TBL] [Abstract] [Full Text] [Related]
9. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract] [Full Text] [Related]
10. Subnuclear re-localization of SOX10 and p54nrb correlates with a unique neurological phenotype associated with SOX10 missense mutations.
Chaoui A; Kavo A; Baral V; Watanabe Y; Lecerf L; Colley A; Mendoza-Londono R; Pingault V; Bondurand N
Hum Mol Genet; 2015 Sep; 24(17):4933-47. PubMed ID: 26060192
[TBL] [Abstract] [Full Text] [Related]
11. nono regulates the intra-S-phase checkpoint in response to UV radiation.
Alfano L; Costa C; Caporaso A; Altieri A; Indovina P; Macaluso M; Giordano A; Pentimalli F
Oncogene; 2016 Feb; 35(5):567-76. PubMed ID: 25893301
[TBL] [Abstract] [Full Text] [Related]
12. Simvastatin reduces melanoma progression in a murine model.
Zanfardino M; Spampanato C; De Cicco R; Buommino E; De Filippis A; Baiano S; Barra A; Morelli F
Int J Oncol; 2013 Dec; 43(6):1763-70. PubMed ID: 24101161
[TBL] [Abstract] [Full Text] [Related]
13. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
[TBL] [Abstract] [Full Text] [Related]
14. Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (nono-NSAIDs) on melanoma cell adhesion.
Cheng H; Mollica MY; Lee SH; Wang L; Velázquez-Martínez CA; Wu S
Toxicol Appl Pharmacol; 2012 Oct; 264(2):161-6. PubMed ID: 22889880
[TBL] [Abstract] [Full Text] [Related]
15. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract] [Full Text] [Related]
16. ABO blood group and incidence of skin cancer.
Xie J; Qureshi AA; Li Y; Han J
PLoS One; 2010 Aug; 5(8):e11972. PubMed ID: 20694147
[TBL] [Abstract] [Full Text] [Related]
17. HLA and ABO antigens in malignant choroidal melanoma.
Völker-Dieben HJ; D'Amaro J; de Lange P; Rouendaal DW
Clin Exp Immunol; 1983 Sep; 53(3):581-8. PubMed ID: 6577995
[TBL] [Abstract] [Full Text] [Related]
